New York, USA – November 9, 2022 – Drosophila Center, the division of CD BioSceinces, is a pioneer in drosophila research focusing on micro-injection, genome editing, cell engineering, genetics, metabolism, neurobiology and other fields. The professional team is dedicated to accelerating the discoveries within the life sciences industry by developing Drosophila-based transgenic and analysis platforms, which help clients to gain unprecedented insight and discover drug targets. Recently, CD BioSciences announced the release of its Drosophila models that can be applied to develop solutions for Drosophila metabolism analysis.
CD BioSciences has a professional gene editing team dedicated to providing comprehensive solutions for Drosophila models in different research fields. Strict quality control procedures guarantee the quality and usability of each model. Leveraging a strong background in Drosophila genomics research and gene editing technologies, CD BioSciences has the ability to customize the most useful models and research protocols for each client, including mechanistic studies of human infection and disease.
Gut microbiota is recognized as the second brain of an organism and is involved in the regulation of various physiological and metabolic activities. CD BioSciences has developed a rigorous sterile Drosophila laboratory capable of providing customers with a wide range of sterile Drosophila models and characterization services.
Gal4-UAS is the most common Drosophila binary regulatory system with multiple variants used to study different gene pathways, tissues and organs. CD BioSciences is dedicated to the construction of Drosophila models to precisely manipulate the spatial/temporal expression of genes using the Gal4-UAS system, and is able to propose modifications and optimizations based on customer needs and objectives.
Mosaic is a widely used Drosophila model. CD BioSciences recommends that clients use chimeras to study cell population development, lethal gene function, monitor subcellular structure, and more. CD BioSciences has a team of scientists proficient in genetic manipulation and supports the construction of Drosophila models with at least two different genotypes.
Q system is also a binary system commonly used in Drosophila. Relying on chemical signals, it is easier to precisely control expression patterns and is often used in neurological studies or in combination with Gal4-UAS. CD BioSciences is committed to the availability and quality of Q System Drosophila models.
Drosophila is highly homologous to the human genome and is widely used in human disease research. CD BioSciences has established a Drosophila genetics platform for human disease research, providing customers with comprehensive solutions for a variety of complex, single-gene genetic diseases.
“We have a professional gene editing team dedicated to providing comprehensive solutions for Drosophila models in different research fields, and strict quality control procedures ensure the quality and usability of each model.” said Marcia Brady, the marketing director of CD Biosciences, she also claimed, “We provide a professional one-stop solution for Drosophila metabolic analysis, and is capable to develop customized solutions for any specific requirements.”
About CD BioSciences
With a mission to provide high-quality and affordable Drosophila products and services, CD BioSciences with a team of experienced experts develops solutions by precise genetic modification of Drosophila as humanized models, as well as diverse phenotypes analysis for fundamental research and drug discovery.